Conflict of Interest: In the last 36 months, Dr. McCoy has received support from the NIH and the American Diabetes Association for projects unrelated to this work; has served as a consultant to EmmiEducate® (Wolters Kluwer) and the Yale-New Haven Health System; and received speaking honoraria and travel support from the American Diabetes Association. Dr. Neumiller receives research funding from the NIH and the American College of Clinical Pharmacy; reports serving as a consultant to Bayer, Eli Lilly, Boehringer Ingelheim, and Proteomics International; and reports receiving other support from the American Diabetes Association for projects unrelated to this work. Dr. Galindo receives research funding from the NIH, Novo Nordisk, Boehringer, Eli Lilly, and Dexcom; and reports consulting/advisory feeds from Abbott Diabetes, Aztra-Zeneca, Bayer, Boehringer, Dexcom, Eli Lilly, Novo Nordisk, and Medtronic. Dr. Umpierrez is supported by research grants from the NIH and has received research support (to Emory University) from Abbott, Dexcom, Corcept, and Bayer, and served as a member of advisory boards for Dexcom, Glucotrack, Corcept, and GlyCare. Dr. Ross currently receives research support through Yale University from Johnson & Johnson to develop methods of clinical trial data sharing, the U.S. Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938), AHRQ, and Arnold Ventures; he formerly received research support from the Medical Device Innovation Consortium as part of the National Evaluation System for Health Technology (NEST); and was an expert witness at the request of Relator's attorneys, the Greene Law Firm, in a qui tam suit alleging violations of the False Claims Act and Anti-Kickback Statute against Biogen Inc. that was settled September 2022. Dr. Herrin currently receives support from the Centers for Medicare and Medicaid Services to develop measures of quality and equity; the NIH, Agency for Healthcare Research and Quality (AHRQ), PCORI, and the American Heart Association (AHA) for multiple research projects. All other authors have no conflicts of interest to disclose.